Stocks
Q32 Bio Inc.QTTB
NASDAQHealthcareBiotechnology$8.41
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for immunology and inflammation. Its lead candidate targets complement-mediated diseases, including a Phase 2 program for dry eye disease. Investors track Q32 Bio for its pipeline potential and recent financing events.
52W Range: $1.91-$23.57
Congressional Interest in Q32 Bio Inc. (QTTB)
No congressional trades have been disclosed for Q32 Bio Inc. (QTTB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading QTTB?
No congressional trades found for this stock.